Yoshitomo Fukuoka1, Akira Nakano1,2, Naoto Tama1, Kanae Hasegawa1, Hiroyuki Ikeda1, Tetsuji Morishita1, Kentaro Ishida1, Kenichi Kaseno1, Naoki Amaya1, Hiroyasu Uzui3, Hidehiko Okazawa4, Hiroshi Tada1. 1. Department of Cardiovascular Medicine, Faculty of Medical Sciences, University of Fukui, 23-3 Shimoaizuki, Matsuoka, Eiheiji-cho, Yoshida-gun, Fukui, 910-1193, Japan. 2. Division of Cardiology, Hikone Municipal Hospital, 1882 Hassakacho, Hikone, Shiga, 522-0057, Japan. 3. Department of Cardiovascular Medicine, Faculty of Medical Sciences, University of Fukui, 23-3 Shimoaizuki, Matsuoka, Eiheiji-cho, Yoshida-gun, Fukui, 910-1193, Japan. huzui@u-fukui.ac.jp. 4. Biomedical Imaging Research Center, Division of Medical Imaging, University of Fukui, 23-3 Shimoaizuki, Matsuoka, Eiheiji-cho, Yoshida-gun, Fukui, 910-1193, Japan.
Abstract
BACKGROUND: In successfully revascularized acute myocardial infarction (AMI), microvascular function in a myocardial flow-glucose metabolism mismatch pattern has not been reported. We aimed to elucidate myocardial flow reserve (MFR) and myocardial viability in mismatch segments. METHODS: 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) and adenosine stress 13N-ammonia PET were performed in eighteen AMI patients to evaluate myocardial glucose metabolism, myocardial blood flow (MBF), and MFR. Infarct segments were classified into 3 groups: normal (preserved resting MBF), mismatch (preserved FDG uptake but reduced resting MBF), and match (reduced FDG uptake and resting MBF). Regional wall motion score (WMS) was assessed immediately after reperfusion and recovery periods. RESULTS: MFR in the mismatch group was significantly lower than that in non-infarct-related segments (1.655 ± 0.516 vs 2.282 ± 0.629, P < .01) and similar to that in the match group (1.635 ± 0.528, P = .999). WMS in the mismatch group was significantly improved (3.07 ± 0.48 vs 2.07 ± 1.14, P = .003); however, in recovery periods, WMS in the mismatch group was significantly higher than that in the normal group (1.05 ± 1.04, P < .01). CONCLUSIONS: In successfully revascularized AMI, microvascular function is impaired despite preserved myocardial glucose metabolism in mismatch segments.
BACKGROUND: In successfully revascularized acute myocardial infarction (AMI), microvascular function in a myocardial flow-glucose metabolism mismatch pattern has not been reported. We aimed to elucidate myocardial flow reserve (MFR) and myocardial viability in mismatch segments. METHODS:18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) and adenosine stress 13N-ammonia PET were performed in eighteen AMI patients to evaluate myocardial glucose metabolism, myocardial blood flow (MBF), and MFR. Infarct segments were classified into 3 groups: normal (preserved resting MBF), mismatch (preserved FDG uptake but reduced resting MBF), and match (reduced FDG uptake and resting MBF). Regional wall motion score (WMS) was assessed immediately after reperfusion and recovery periods. RESULTS: MFR in the mismatch group was significantly lower than that in non-infarct-related segments (1.655 ± 0.516 vs 2.282 ± 0.629, P < .01) and similar to that in the match group (1.635 ± 0.528, P = .999). WMS in the mismatch group was significantly improved (3.07 ± 0.48 vs 2.07 ± 1.14, P = .003); however, in recovery periods, WMS in the mismatch group was significantly higher than that in the normal group (1.05 ± 1.04, P < .01). CONCLUSIONS: In successfully revascularized AMI, microvascular function is impaired despite preserved myocardial glucose metabolism in mismatch segments.
Authors: Hein J Verberne; Gerrit W Sloof; Arnold L Beets; Anne M Murphy; Berthe L F van Eck-Smit; Furn F Knapp Journal: Eur J Nucl Med Mol Imaging Date: 2003-03 Impact factor: 9.236
Authors: Riikka Lautamäki; Karl H Schuleri; Tetsuo Sasano; Mehrbod S Javadi; Amr Youssef; Jennifer Merrill; Stephan G Nekolla; M Roselle Abraham; Albert C Lardo; Frank M Bengel Journal: Circ Cardiovasc Imaging Date: 2009-05-15 Impact factor: 7.792
Authors: Fernanda Erthal; Natasha Aleksova; Aun Yeong Chong; Robert A de Kemp; Rob S B Beanlands Journal: J Nucl Cardiol Date: 2016-07-05 Impact factor: 5.952